DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kimpton M, Wells PS, Carrier M.
Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: rational and design of the AVERT trial.
Thromb Res 2018;
164 (Suppl. 01) S124-S129
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.